Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute

Phase

3

Study type

Industry Sponsored

Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

    Lead investigator    
            Dr Daman Langguth        

        Clinical trial coordinator		
				Venita Bali			

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

Latest News

Meet Yena who is helping shape Clinical Trials at Wesley Research Institute

We had the chance to chat with Yena Ng for an insider peek at her experience over the past year, from her university placement to becoming an integral part of the Wesley Research Institute team.

A Survivor’s Fight Against ARDS

Former Queensland Senator the Hon Ron Boswell AO knows the terrifying reality of Acute Respiratory Distress Syndrome (ARDS) all too well. Now Mr Boswell is proudly supporting groundbreaking new ARDS research funded by Wesley Research Institute and led by some of Brisbane’s finest critical care specialists.

Queensland Researchers Launch New Fight Against Deadly Lung Syndrome

A team of Queensland researchers is revolutionising the fight against a devastating lung condition that affects up to five million people globally each year.

1 2 3 … 31 Next »

Rare Diseases

Testing treatments to improve symptoms of Myositis